About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalChina
Team (8)
BIN XIE, MS
Kangpu Biopharmaceuticals
team_member
CHUANSHENG GE, PhD
Kangpu Biopharmaceuticals
team_member
CHUANSHENG GE,PhD
Kangpu Biopharmaceuticals
team_member
LINSHENG HE, MS
Kangpu Biopharmaceuticals
team_member
LIPING MENG, PhD
Kangpu Biopharmaceuticals
team_member
PANDY SONG, PhD
Kangpu Biopharmaceuticals
team_member
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
150
By Phase
PHASE1: 3PHASE1/PHASE2: 1
By Status
COMPLETED: 4
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT04283097Lead Sponsor
Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects
PHASE1Completed
30 participants
Started: Sep 13, 2021 · Completed: Dec 12, 2024
NCT04643067Lead Sponsor
Phase 1b/2a Study to Evaluate Safety and Efficacy of KPG-818 in SLE
PHASE1/PHASE2Completed
64 participants
Started: Jun 3, 2021 · Completed: Aug 18, 2023
NCT03569280Lead Sponsor
Evaluation of Safety and Efficacy of KPG-121 Plus Enzalutamide, Abiraterone or Apalutamide in CRPC Patients
PHASE1Completed
16 participants
Started: Nov 26, 2019 · Completed: Jun 15, 2023
NCT03949426Lead Sponsor
Safety, Tolerability and Pharmacokinetics of KPG-818 in Healthy Subjects
PHASE1Completed
40 participants
Started: May 1, 2019 · Completed: Sep 29, 2019
Locations (1)
Headquarters
Shanghai, China
Map
Loading map...